|
Video: What is a Stock Split?
|
|
Evelo Biosciences is discovering and developing a class of medicines that are intended to act on cells in the small intestine to produce therapeutic effects throughout the body. The target cells in the small intestine play a role in governing human immune, metabolic and neurologic systems. Co.'s product candidates are orally delivered pharmaceutical preparations of naturally occurring, specific single strains of microbes or microbial extracellular vesicles. Co.'s product candidate, EDP1815, is being developed for the treatment of inflammatory diseases. Additional product candidates in development include EDP1867 and EDP2939 for the treatment of inflammatory disease. According to our EVLO split history records, EVLO has had 1 split. | |
|
EVLO (EVLO) has 1 split in our EVLO split history database. The split for EVLO took place on June 30, 2023. This was a 1 for 20 reverse split, meaning for each 20 shares of EVLO owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 50 share position following the split.
When a company such as EVLO conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.
Looking at the EVLO split history from start to finish, an original position size of 1000 shares would have turned into 50 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into EVLO shares, starting with a $10,000 purchase of EVLO, presented on a split-history-adjusted basis factoring in the complete EVLO split history.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
05/09/2018 |
|
End date: |
07/01/2024 |
|
Start price/share: |
$325.00 |
|
End price/share: |
$0.06 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-99.98% |
|
Average Annual Total Return: |
-75.29% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$1.84 |
|
Years: |
6.15 |
|
|
|
Date |
Ratio |
06/30/2023 | 1 for 20 |
|
|